Advertisement

Index by author

March 01, 1985; Volume 13,Issue 2

A

  1. Awni, W M

    1. The pharmacokinetics of cyclosporine. I. Single dose and constant rate infusion studies in the rabbit.
      W M Awni and R J Sawchuk
      Drug Metabolism and Disposition March 1985, 13 (2) 127-132;
    2. The pharmacokinetics of cyclosporine. II. Blood plasma distribution and binding studies.
      W M Awni and R J Sawchuk
      Drug Metabolism and Disposition March 1985, 13 (2) 133-138;

B

  1. Baba, S

    1. Species differences in the metabolism of suprofen in laboratory animals and man.
      Y Mori, N Kuroda, Y Sakai, F Yokoya, K Toyoshi and S Baba
      Drug Metabolism and Disposition March 1985, 13 (2) 239-245;

  2. Bellah, J

    1. Effect of chronic ethanol consumption on activation of nitrosopyrrolidine to a mutagen by rat upper alimentary tract, lung, and hepatic tissue.
      F Farinati, Z Zhou, J Bellah, C S Lieber and A J Garro
      Drug Metabolism and Disposition March 1985, 13 (2) 210-214;

  3. Bonati, M

    1. Pharmacokinetics of paraxanthine, one of the primary metabolites of caffeine, in the rat.
      A Bortolotti, L Jiritano and M Bonati
      Drug Metabolism and Disposition March 1985, 13 (2) 227-231;

  4. Bortolotti, A

    1. Pharmacokinetics of paraxanthine, one of the primary metabolites of caffeine, in the rat.
      A Bortolotti, L Jiritano and M Bonati
      Drug Metabolism and Disposition March 1985, 13 (2) 227-231;

C

  1. Chabard, J L

    1. Metabolic disposition of 2-chloroethyl nitrosocarbamoylcystamine in rats.
      D Godeneche, J C Madelmont, M F Moreau, J Duprat, J L Chabard, R Plagne and G Meyniel
      Drug Metabolism and Disposition March 1985, 13 (2) 220-226;

  2. Coon, M J

    1. Evaluation of the role of free hydroxyl radicals in the cytochrome P-450-catalyzed oxidation of benzene and cyclohexanol.
      L D Gorsky and M J Coon
      Drug Metabolism and Disposition March 1985, 13 (2) 169-174;

  3. Crooks, P A

    1. Stereospecific in vivo N-methylation of nicotine in the guinea pig.
      K C Cundy, M Sato and P A Crooks
      Drug Metabolism and Disposition March 1985, 13 (2) 175-185;

  4. Cundy, K C

    1. Stereospecific in vivo N-methylation of nicotine in the guinea pig.
      K C Cundy, M Sato and P A Crooks
      Drug Metabolism and Disposition March 1985, 13 (2) 175-185;

D

  1. Davis, M E

    1. Prevention of chlorphentermine-induced pulmonary phospholipidosis in rats by phenobarbital.
      M J Reasor and M E Davis
      Drug Metabolism and Disposition March 1985, 13 (2) 192-196;

  2. Dees, J H

    1. Drug metabolism by isolated fetal human hepatocytes in suspension and primary culture.
      P Wiebkin, J H Dees, J M Mathis and R A Prough
      Drug Metabolism and Disposition March 1985, 13 (2) 163-168;

  3. Duprat, J

    1. Metabolic disposition of 2-chloroethyl nitrosocarbamoylcystamine in rats.
      D Godeneche, J C Madelmont, M F Moreau, J Duprat, J L Chabard, R Plagne and G Meyniel
      Drug Metabolism and Disposition March 1985, 13 (2) 220-226;

E

  1. Eadsforth, C V

    1. n-Butylglycidyl ether: the formation of a novel metabolite of an epoxide.
      C V Eadsforth, C J Logan, J A Page and P D Regan
      Drug Metabolism and Disposition March 1985, 13 (2) 263-264;

F

  1. Farinati, F

    1. Effect of chronic ethanol consumption on activation of nitrosopyrrolidine to a mutagen by rat upper alimentary tract, lung, and hepatic tissue.
      F Farinati, Z Zhou, J Bellah, C S Lieber and A J Garro
      Drug Metabolism and Disposition March 1985, 13 (2) 210-214;

  2. Fischer, L J

    1. Studies on the fate of the glutathione and cysteine conjugates of acetaminophen in mice.
      L J Fischer, M D Green and A W Harman
      Drug Metabolism and Disposition March 1985, 13 (2) 121-126;

  3. Frankhuijzen-Sierevogel, A C

    1. Glucuronidation of morphine and six beta 2-sympathomimetics in isolated rat intestinal epithelial cells.
      A S Koster, A C Frankhuijzen-Sierevogel and J Noordhoek
      Drug Metabolism and Disposition March 1985, 13 (2) 232-238;

G

  1. Garro, A J

    1. Effect of chronic ethanol consumption on activation of nitrosopyrrolidine to a mutagen by rat upper alimentary tract, lung, and hepatic tissue.
      F Farinati, Z Zhou, J Bellah, C S Lieber and A J Garro
      Drug Metabolism and Disposition March 1985, 13 (2) 210-214;

  2. Godeneche, D

    1. Metabolic disposition of 2-chloroethyl nitrosocarbamoylcystamine in rats.
      D Godeneche, J C Madelmont, M F Moreau, J Duprat, J L Chabard, R Plagne and G Meyniel
      Drug Metabolism and Disposition March 1985, 13 (2) 220-226;

  3. Gorsky, L D

    1. Evaluation of the role of free hydroxyl radicals in the cytochrome P-450-catalyzed oxidation of benzene and cyclohexanol.
      L D Gorsky and M J Coon
      Drug Metabolism and Disposition March 1985, 13 (2) 169-174;

  4. Green, M D

    1. Studies on the fate of the glutathione and cysteine conjugates of acetaminophen in mice.
      L J Fischer, M D Green and A W Harman
      Drug Metabolism and Disposition March 1985, 13 (2) 121-126;

H

  1. Harman, A W

    1. Studies on the fate of the glutathione and cysteine conjugates of acetaminophen in mice.
      L J Fischer, M D Green and A W Harman
      Drug Metabolism and Disposition March 1985, 13 (2) 121-126;

  2. Harvey, D J

    1. Studies on the beta-oxidative metabolism of delta 1- and delta 6-tetrahydrocannabinol in the mouse. The in vivo biotransformation of metabolites oxidized in the side chain.
      D J Harvey and J T Leuschner
      Drug Metabolism and Disposition March 1985, 13 (2) 215-219;

  3. Hashimura, Y

    1. In vitro metabolism of the new cardiotonic agent denopamine (TA-064) by rat and rabbit liver preparations. Oxidation, methylation, and glucuronidation.
      T Suzuki, Y Hashimura and S Takeyama
      Drug Metabolism and Disposition March 1985, 13 (2) 246-254;

  4. Hultin, T A

    1. Genetic differences in 2-aminofluorene pharmacokinetics between intact C57BL/6J and A/J mice.
      T A Hultin and W W Weber
      Drug Metabolism and Disposition March 1985, 13 (2) 148-150;

I

  1. Inaba, T

    1. Mephenytoin metabolism in vitro by human liver.
      M Jurima, T Inaba and W Kalow
      Drug Metabolism and Disposition March 1985, 13 (2) 151-155;

  2. Isom, G E

    1. Pharmacokinetic analysis of potassium cyanate in mice using whole blood and expired air.
      J D Johnson, P R Mayer and G E Isom
      Drug Metabolism and Disposition March 1985, 13 (2) 260-262;

J

  1. Jiritano, L

    1. Pharmacokinetics of paraxanthine, one of the primary metabolites of caffeine, in the rat.
      A Bortolotti, L Jiritano and M Bonati
      Drug Metabolism and Disposition March 1985, 13 (2) 227-231;

  2. Johnson, J D

    1. Pharmacokinetic analysis of potassium cyanate in mice using whole blood and expired air.
      J D Johnson, P R Mayer and G E Isom
      Drug Metabolism and Disposition March 1985, 13 (2) 260-262;

  3. Jurima, M

    1. Mephenytoin metabolism in vitro by human liver.
      M Jurima, T Inaba and W Kalow
      Drug Metabolism and Disposition March 1985, 13 (2) 151-155;

K

  1. Kalow, W

    1. Mephenytoin metabolism in vitro by human liver.
      M Jurima, T Inaba and W Kalow
      Drug Metabolism and Disposition March 1985, 13 (2) 151-155;

  2. Kirkland, K M

    1. Tracazolate metabolites in rat tissue.
      F R Zuleski, K M Kirkland, M D Melgar and J O Malbica
      Drug Metabolism and Disposition March 1985, 13 (2) 139-147;

  3. Klaassen, C D

    1. Development of UDP-glucuronosyltransferase activity toward digitoxigenin-monodigitoxoside in neonatal rats.
      J B Watkins and C D Klaassen
      Drug Metabolism and Disposition March 1985, 13 (2) 186-191;

  4. Koster, A S

    1. Glucuronidation of morphine and six beta 2-sympathomimetics in isolated rat intestinal epithelial cells.
      A S Koster, A C Frankhuijzen-Sierevogel and J Noordhoek
      Drug Metabolism and Disposition March 1985, 13 (2) 232-238;

  5. Kulkarni, A P

    1. Polyamine effects on cytochrome P-450- and flavin-containing monooxygenase-mediated oxidation of xenobiotics.
      T G Osimitz and A P Kulkarni
      Drug Metabolism and Disposition March 1985, 13 (2) 197-203;

  6. Kuroda, N

    1. Species differences in the metabolism of suprofen in laboratory animals and man.
      Y Mori, N Kuroda, Y Sakai, F Yokoya, K Toyoshi and S Baba
      Drug Metabolism and Disposition March 1985, 13 (2) 239-245;

L

  1. Leuschner, J T

    1. Studies on the beta-oxidative metabolism of delta 1- and delta 6-tetrahydrocannabinol in the mouse. The in vivo biotransformation of metabolites oxidized in the side chain.
      D J Harvey and J T Leuschner
      Drug Metabolism and Disposition March 1985, 13 (2) 215-219;

  2. Lieber, C S

    1. Effect of chronic ethanol consumption on activation of nitrosopyrrolidine to a mutagen by rat upper alimentary tract, lung, and hepatic tissue.
      F Farinati, Z Zhou, J Bellah, C S Lieber and A J Garro
      Drug Metabolism and Disposition March 1985, 13 (2) 210-214;

  3. Logan, C J

    1. n-Butylglycidyl ether: the formation of a novel metabolite of an epoxide.
      C V Eadsforth, C J Logan, J A Page and P D Regan
      Drug Metabolism and Disposition March 1985, 13 (2) 263-264;

M

  1. Madelmont, J C

    1. Metabolic disposition of 2-chloroethyl nitrosocarbamoylcystamine in rats.
      D Godeneche, J C Madelmont, M F Moreau, J Duprat, J L Chabard, R Plagne and G Meyniel
      Drug Metabolism and Disposition March 1985, 13 (2) 220-226;

  2. Malbica, J O

    1. Tracazolate metabolites in rat tissue.
      F R Zuleski, K M Kirkland, M D Melgar and J O Malbica
      Drug Metabolism and Disposition March 1985, 13 (2) 139-147;

  3. Maldonado, A L

    1. The effect of ketoconazole on hepatic oxidative drug metabolism in the rat in vivo and in vitro.
      C G Meredith, A L Maldonado and K V Speeg
      Drug Metabolism and Disposition March 1985, 13 (2) 156-162;

  4. Mathis, J M

    1. Drug metabolism by isolated fetal human hepatocytes in suspension and primary culture.
      P Wiebkin, J H Dees, J M Mathis and R A Prough
      Drug Metabolism and Disposition March 1985, 13 (2) 163-168;

  5. Mayer, P R

    1. Pharmacokinetic analysis of potassium cyanate in mice using whole blood and expired air.
      J D Johnson, P R Mayer and G E Isom
      Drug Metabolism and Disposition March 1985, 13 (2) 260-262;

  6. Melgar, M D

    1. Tracazolate metabolites in rat tissue.
      F R Zuleski, K M Kirkland, M D Melgar and J O Malbica
      Drug Metabolism and Disposition March 1985, 13 (2) 139-147;

  7. Meredith, C G

    1. The effect of ketoconazole on hepatic oxidative drug metabolism in the rat in vivo and in vitro.
      C G Meredith, A L Maldonado and K V Speeg
      Drug Metabolism and Disposition March 1985, 13 (2) 156-162;

  8. Meyniel, G

    1. Metabolic disposition of 2-chloroethyl nitrosocarbamoylcystamine in rats.
      D Godeneche, J C Madelmont, M F Moreau, J Duprat, J L Chabard, R Plagne and G Meyniel
      Drug Metabolism and Disposition March 1985, 13 (2) 220-226;

  9. Moreau, M F

    1. Metabolic disposition of 2-chloroethyl nitrosocarbamoylcystamine in rats.
      D Godeneche, J C Madelmont, M F Moreau, J Duprat, J L Chabard, R Plagne and G Meyniel
      Drug Metabolism and Disposition March 1985, 13 (2) 220-226;

  10. Mori, Y

    1. Species differences in the metabolism of suprofen in laboratory animals and man.
      Y Mori, N Kuroda, Y Sakai, F Yokoya, K Toyoshi and S Baba
      Drug Metabolism and Disposition March 1985, 13 (2) 239-245;

N

  1. Noordhoek, J

    1. Glucuronidation of morphine and six beta 2-sympathomimetics in isolated rat intestinal epithelial cells.
      A S Koster, A C Frankhuijzen-Sierevogel and J Noordhoek
      Drug Metabolism and Disposition March 1985, 13 (2) 232-238;

O

  1. Olanoff, L S

    1. Quantitative account of propranolol metabolism in urine of normal man.
      T Walle, U K Walle and L S Olanoff
      Drug Metabolism and Disposition March 1985, 13 (2) 204-209;

  2. Osimitz, T G

    1. Polyamine effects on cytochrome P-450- and flavin-containing monooxygenase-mediated oxidation of xenobiotics.
      T G Osimitz and A P Kulkarni
      Drug Metabolism and Disposition March 1985, 13 (2) 197-203;

P

  1. Page, J A

    1. n-Butylglycidyl ether: the formation of a novel metabolite of an epoxide.
      C V Eadsforth, C J Logan, J A Page and P D Regan
      Drug Metabolism and Disposition March 1985, 13 (2) 263-264;

  2. Plagne, R

    1. Metabolic disposition of 2-chloroethyl nitrosocarbamoylcystamine in rats.
      D Godeneche, J C Madelmont, M F Moreau, J Duprat, J L Chabard, R Plagne and G Meyniel
      Drug Metabolism and Disposition March 1985, 13 (2) 220-226;

  3. Prough, R A

    1. Drug metabolism by isolated fetal human hepatocytes in suspension and primary culture.
      P Wiebkin, J H Dees, J M Mathis and R A Prough
      Drug Metabolism and Disposition March 1985, 13 (2) 163-168;

R

  1. Reasor, M J

    1. Prevention of chlorphentermine-induced pulmonary phospholipidosis in rats by phenobarbital.
      M J Reasor and M E Davis
      Drug Metabolism and Disposition March 1985, 13 (2) 192-196;

  2. Regan, P D

    1. n-Butylglycidyl ether: the formation of a novel metabolite of an epoxide.
      C V Eadsforth, C J Logan, J A Page and P D Regan
      Drug Metabolism and Disposition March 1985, 13 (2) 263-264;

S

  1. Sakai, Y

    1. Species differences in the metabolism of suprofen in laboratory animals and man.
      Y Mori, N Kuroda, Y Sakai, F Yokoya, K Toyoshi and S Baba
      Drug Metabolism and Disposition March 1985, 13 (2) 239-245;

  2. Sato, M

    1. Stereospecific in vivo N-methylation of nicotine in the guinea pig.
      K C Cundy, M Sato and P A Crooks
      Drug Metabolism and Disposition March 1985, 13 (2) 175-185;

  3. Sawchuk, R J

    1. The pharmacokinetics of cyclosporine. I. Single dose and constant rate infusion studies in the rabbit.
      W M Awni and R J Sawchuk
      Drug Metabolism and Disposition March 1985, 13 (2) 127-132;
    2. The pharmacokinetics of cyclosporine. II. Blood plasma distribution and binding studies.
      W M Awni and R J Sawchuk
      Drug Metabolism and Disposition March 1985, 13 (2) 133-138;

  4. Speeg, K V

    1. The effect of ketoconazole on hepatic oxidative drug metabolism in the rat in vivo and in vitro.
      C G Meredith, A L Maldonado and K V Speeg
      Drug Metabolism and Disposition March 1985, 13 (2) 156-162;

  5. Streeter, A J

    1. The in vitro metabolism of hydralazine.
      A J Streeter and J A Timbrell
      Drug Metabolism and Disposition March 1985, 13 (2) 255-259;

  6. Suzuki, T

    1. In vitro metabolism of the new cardiotonic agent denopamine (TA-064) by rat and rabbit liver preparations. Oxidation, methylation, and glucuronidation.
      T Suzuki, Y Hashimura and S Takeyama
      Drug Metabolism and Disposition March 1985, 13 (2) 246-254;

T

  1. Takeyama, S

    1. In vitro metabolism of the new cardiotonic agent denopamine (TA-064) by rat and rabbit liver preparations. Oxidation, methylation, and glucuronidation.
      T Suzuki, Y Hashimura and S Takeyama
      Drug Metabolism and Disposition March 1985, 13 (2) 246-254;

  2. Timbrell, J A

    1. The in vitro metabolism of hydralazine.
      A J Streeter and J A Timbrell
      Drug Metabolism and Disposition March 1985, 13 (2) 255-259;

  3. Toyoshi, K

    1. Species differences in the metabolism of suprofen in laboratory animals and man.
      Y Mori, N Kuroda, Y Sakai, F Yokoya, K Toyoshi and S Baba
      Drug Metabolism and Disposition March 1985, 13 (2) 239-245;

W

  1. Wagner, J G

    1. Relationships among the venous equilibration ("well-stirred") model, the sinusoidal perfusion ("parallel-tube") model, and a specific two-compartment open model.
      J G Wagner
      Drug Metabolism and Disposition March 1985, 13 (2) 119-120;

  2. Walle, T

    1. Quantitative account of propranolol metabolism in urine of normal man.
      T Walle, U K Walle and L S Olanoff
      Drug Metabolism and Disposition March 1985, 13 (2) 204-209;

  3. Walle, U K

    1. Quantitative account of propranolol metabolism in urine of normal man.
      T Walle, U K Walle and L S Olanoff
      Drug Metabolism and Disposition March 1985, 13 (2) 204-209;

  4. Watkins, J B

    1. Development of UDP-glucuronosyltransferase activity toward digitoxigenin-monodigitoxoside in neonatal rats.
      J B Watkins and C D Klaassen
      Drug Metabolism and Disposition March 1985, 13 (2) 186-191;

  5. Weber, W W

    1. Genetic differences in 2-aminofluorene pharmacokinetics between intact C57BL/6J and A/J mice.
      T A Hultin and W W Weber
      Drug Metabolism and Disposition March 1985, 13 (2) 148-150;

  6. Wiebkin, P

    1. Drug metabolism by isolated fetal human hepatocytes in suspension and primary culture.
      P Wiebkin, J H Dees, J M Mathis and R A Prough
      Drug Metabolism and Disposition March 1985, 13 (2) 163-168;

Y

  1. Yokoya, F

    1. Species differences in the metabolism of suprofen in laboratory animals and man.
      Y Mori, N Kuroda, Y Sakai, F Yokoya, K Toyoshi and S Baba
      Drug Metabolism and Disposition March 1985, 13 (2) 239-245;

Z

  1. Zhou, Z

    1. Effect of chronic ethanol consumption on activation of nitrosopyrrolidine to a mutagen by rat upper alimentary tract, lung, and hepatic tissue.
      F Farinati, Z Zhou, J Bellah, C S Lieber and A J Garro
      Drug Metabolism and Disposition March 1985, 13 (2) 210-214;

  2. Zuleski, F R

    1. Tracazolate metabolites in rat tissue.
      F R Zuleski, K M Kirkland, M D Melgar and J O Malbica
      Drug Metabolism and Disposition March 1985, 13 (2) 139-147;
Back to top

In this issue

Drug Metabolism and Disposition
Vol. 13, Issue 2
1 Mar 1985
Sign up for alerts